Global Transplant Diagnostics Market to Reach USD 1,802.0 Million by 2033, Bolstered by Increasing Prevalence of Chronic Diseases

December 27, 2024 | Healthcare

The latest report by IMARC Group, titled “Transplant Diagnostics Market Report by Component (Instrument and Equipment, Reagent and Consumables, Software and Services), Technology (Non-Molecular Assay, Molecular Assay), Organ Type (Kidney, Liver, Heart, Lung, Pancreas, and Others), Application (Pre-Transplant Diagnostics, Post-Transplant Diagnostics), End User (Hospitals and Transplant Centers, Research Laboratories and Academic Institutes, Commercial Service Providers), and Region 2025-2033,” finds that the global transplant diagnostics market size reached USD 939.3 Million in 2024. Transplant diagnostics refer to various tests conducted for checking the compatibility between the organ donor and recipient before or after the transplant. They increase the chances of organ survival and minimize serious transplant complications. Owing to these properties, transplant diagnostics finds extensive applications across various disciplines, such as pathology, immunogenetics, infectious diseases, molecular diagnostics, therapeutic drug monitoring, and human leukocyte antigens (HLA) typing and monitoring.

Global Transplant Diagnostics Market Trends:

The market is primarily driven by the growing prevalence of chronic diseases due to the increasing consumption of processed food products and the escalating number of individuals that consume tobacco and alcohol products causing organ failures. In addition, the rising number of blood donors is escalating the demand for transplant diagnostics to ensure the compatibility of donor-recipient and improve the quality of life of transplant patients. Besides this, manufacturers are offering advanced antibody detection products, laboratory instrumentation, and computer software that can be utilized to simplify and automate testing procedures and final test evaluations. This, coupled with the rising number of severe road accidents or collisions, is also escalating the demand for organ transplantation and its diagnostics. Moreover, several healthcare firms are focusing on developing innovative, high-quality HLA products for clinical and research applications, which is further propelling market growth. Looking forward, IMARC Group expects the market value to reach USD 1,802.0 Million by 2033, exhibiting a CAGR of 7.13% during the forecast period (2025-2033).

Market Summary:

  • Based on the component, the market has been segmented into instrument and equipment, reagents and consumables, and software and services. 
  • On the basis of technology, the market has been bifurcated into non-molecular (serological assay and mixed lymphocyte culture) and molecular assay (PC-based and sequencing-based). 
  • Based on the organ type, the market has been classified into kidney, liver, heart, lung, pancreas, and others. 
  • On the basis of the application, the market has been segregated into pre-transplant and post-transplant diagnostics. 
  • Based on the end user, the market has been categorized into hospitals and transplant centers, research laboratories and academic institutes, and commercial service providers. 
  • Region-wise, the market has been divided into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
  • The competitive landscape of the market has been examined in the report, with some of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Hologic Inc, Illumina Inc., Immucor Inc. (IVD Holdings Inc.), Merck KGaA, Qiagen N.V., and Thermo Fisher Scientific Inc.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Component, Technology, Organ Type, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Hologic Inc, Illumina Inc., Immucor Inc. (IVD Holdings Inc.), Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Transplant Diagnostics Market to Reach USD 1,802.0 Million by 2033, Bolstered by Increasing Prevalence of Chronic Diseases
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials